Adjunctive GLP-1RAs cut HbA1c **0.23%** and body weight **3.93 kg** in **Type 1 Diabetes**.
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists as Adjuncts to Insulin Therapy in Type 1 Diabetes Mellitus: An Overlap-Informed Umbrella Review.
Abstract
Adjunctive GLP-1RAs reduced HbA1c by 0.23% and body weight by 3.93 kg in Type 1 Diabetes patients receiving insulin.
